In December 2025, Novo Nordisk launched an oral semaglutide formulation that leverages AI driven demand analytics to align production with regional uptake patterns, improving supply efficiency and supporting broader market adoption and reinforcing the competitive edge of the portfolio while providing clinicians with a convenient oral option
Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans For Drugs Used to Treat Diabetes, Plans Almost Always Require Prior Authorization or Other Utilization Management Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data
A: Yes, CJC-1295 is a synthetic peptide classified under growth hormone-releasing hormone analogs used in peptide therapy
drive-through temptation
Liver issues are uncommon on GLP-1s, but contact your healthcare provider if you notice persistent fatigue beyond typical medication adjustment, upper right abdominal discomfort, dark urine or pale stools, yellowing of the skin or eyes, or nausea that worsens rather than improves over time
Tirzepatide left out of the refrigerator for extended periods loses potency
